Our partners in Europe!
We collaborate with a wide range of organizations to draw on their expertise and to ensure the highest coordination in development efforts. These partnerships help us reach our goals and desired targets with the necessary support, while boosting the efficiency and effectiveness of development aid.
The involved Department is the R&D one that was established in 2018 specializing in research funding in health and social matters in collaborative competitive calls at EU and international levels. We participate, both as coordinator and partner, in several research projects funded by the European Union such as HORIZON 2020, ERASMUS+ and EEA Grants, the Cyprus Research Promotion Foundation and other sources.
IFIGENEIA
Participation in the IFIGENEIA project offers PASYKAF significant organizational benefits and strategic opportunities for long-term impact. As a core societal actor in the Cypriot Excellence Hub, PASYKAF plays a key role in Work Package 2, focusing on communication, education, inclusion, and citizen engagement.
This involvement enables PASYKAF to co-create educational modules for healthcare professionals, deliver patient-centered workshops on the benefits of nuclear medicine, and organize public engagement activities. These actions strengthen PASYKAF’s position as a leader in health literacy, public education, and advocacy in Cyprus.
The collaboration also broadens its influence across the European Research Area by contributing to cutting-edge nuclear medicine innovation. Through exposure to novel technologies, partnerships with leading academic and industrial players, and access to regional and European funding strategies, PASYKAF enhances its internal capacity, visibility, and sustainability.
Ultimately, the project reinforces PASYKAF’s strategic growth in cancer care and policy influence while increasing its societal relevance by bridging the gap between research and patients.
SUNRISE
An innovative cancer prevention initiative
PASYKAF’s participation in the SUNRISE project provides valuable benefits and long-term impact as a key contributor to the sustainable implementation and communication of cancer prevention programs for adolescents across Europe.
As the lead beneficiary of WP2 – Sustainable implementation of cancer prevention programme enhanced with digital tools and co-leader in several other work packages, PASYKAF plays a pivotal role in designing and promoting sustainable, multicultural cancer prevention strategies, including the creation of educational content and interactive tools tailored to different socio-economic and cultural adolescent groups.
This involvement significantly strengthens PASYKAF’s internal capacity in behaviour-change science, digital health promotion, and implementation planning. Through its leadership in training, PASYKAF reinforces its educational role and extends its influence in school-based cancer prevention across Cyprus and beyond.
Additionally, its contributions to dissemination activities and policy engagement solidify its visibility and advocacy power at the European level. The project enhances PASYKAF’s institutional knowledge and national and European partnerships and collaborations, enabling the organization to continue leveraging the tools, networks, and methodologies developed during SUNRISE well beyond the project’s duration.
DESIPOC
PASYKAF’s participation in the DESIPOC project brings significant organizational benefits and long-term impact.
Through its active involvement in training, engaging national experts, and supporting vulnerable groups, PASYKAF enhances its internal capacity and staff expertise in psychosocial oncology and digital care delivery. The organization gains increased visibility and credibility at both national and European levels.
Participation in DESIPOC will allow PASYKAF to influence healthcare policy through co-creation of recommendations and policy engagement activities, thereby expanding its advocacy reach. The project also strengthens PASYKAF’s professional network across Europe, fostering opportunities for future collaboration and EU-funded initiatives.
Importantly, the tools, resources, and training developed through DESIPOC will be sustainable and reusable, supporting PASYKAF’s ongoing psycho-oncological services and educational programs.
Overall, DESIPOC empowers PASYKAF to improve service delivery, contribute to European cancer care strategies, and grow institutionally as a leader in patient-centered, evidence-based psycho-oncology care.
The new Joint Action eCAN+, has as main aim to make the advantages of digital health available to all citizens, patients, and healthcare professionals, with the goal of advancing cancer prevention and care throughout Europe. This initiative, part of the EU4Health Programme and aligned with Europe’s Beating Cancer Plan, will run until 2029.
Over a four-year period, eCAN+ will bring together 81 partners across 23 European countries, including Cyprus. This project includes the participation and involvement of public health institutes, universities, hospitals, cancer centres, and patient associations. These stakeholders will collaborate to improve eHealth, telemedicine, and remote monitoring systems, as well as to expand access to and exchange of health data within both current and future cancer centres.
Building on the priorities and recommendations of the eCAN Joint Action (2022–2024), eCAN+ addresses the pressing need for cross-border health data sharing in cancer care. The specific objectives of the project include:
- Launching a comprehensive training programme to develop digital skills.
- Strengthening digital collaboration within and among cancer centres.
- Implementing clinical telemedicine applications across various cancer care settings.
- Enhancing readiness for the European Health Data Space (EHDS).
In addition, eCAN+ will establish a framework for testing and piloting the secure and compliant integration of digital tools—such as telemedicine applications—ensuring adherence to all relevant EU regulations, including the General Data Protection Regulation (GDPR), the Medical Device Regulation (MDR), and the upcoming EHDS Regulation. The main aim is to improve the effective use of digital technologies in cancer treatment.
JOINT ACTION ECAN
Participation in the eCAN project brought significant benefits and lasting impact to PASYKAF. As a key partner, PASYKAF contributed its deep expertise in patient support and education to help shape digital health solutions tailored to cancer care.
Following the GATEKEEPER project, this involvement allowed PASYKAF to expand its knowledge and capacity in telehealth, telemonitoring, and teleconsultation technologies, enhancing its ability to support cancer patients face-to-face and via teleconsultation.
Through active participation in the design and delivery of pilot studies and training programs, PASYKAF strengthens its role as a national leader in integrating innovative healthcare approaches. The organization benefited from collaboration with top medical, academic, and technology partners across Europe, which fostered knowledge exchange and capacity building.
Additionally, eCAN enabled PASYKAF to directly influence the development of patient-centered digital tools, ensuring these reflect real needs and local care practices. This experience positions PASYKAF to more effectively advocate for policies that support telemedicine and to apply the outcomes of the project to improve service delivery in Cyprus.
Overall, the project empowers PASYKAF to grow its impact, modernize its services, and solidify its role in shaping the future of cancer care.
PROTECT EUROPE
PASYKAF’s participation in the PROTECT-EUROPE project, particularly in Work Packages 1 and 3, offered substantial benefits to the organization.
Through its role in project coordination and public health communications, PASYKAF strengthened its expertise in managing EU health projects and gained valuable experience in developing and promoting targeted messaging to increase HPV vaccination uptake.
By focusing on examining the role of wider public health messaging and designing effective communication strategies, PASYKAF was able to directly support the creation of culturally relevant, gender-neutral HPV vaccine campaigns—a key area of need in Cyprus. This also enhanced its ability to tailor messaging for parents, youth, and healthcare professionals using age-appropriate and context-specific approaches.
The project allowed PASYKAF to collaborate with leading organizations and experts across Europe, significantly expanding its professional network and positioning the organization as a credible actor in European vaccination and cancer prevention efforts.
INCISIVE PROJECT
PASYKAF’s participation in the INCISIVE project offered valuable opportunities for growth, innovation, and impact.
As a key partner in this AI-based cancer imaging initiative, PASYKAF contributed in a consultative role, learning about new technologies and how they can be used to improve cancer diagnosis and care. Importantly, PASYKAF represented the voice of patients throughout the project, ensuring their needs and concerns were considered in the development of digital solutions.
The organization also collected and provided medical scans from patients, which were used to help build a predictive model aimed at identifying cancer metastasis early. Through this involvement, PASYKAF strengthened its capacity in digital health advocacy and patient-centered innovation, while gaining firsthand experience with cutting-edge tools in cancer imaging and follow-up.
The collaboration allowed PASYKAF to work alongside leading research, medical, and technology institutions across Europe, expanding its professional network and visibility in the fields of cancer care and artificial intelligence.
BUMPER
PASYKAF’s involvement in the BUMPER project brought clear and practical benefits.
As an active partner in key areas such as user testing, content validation, training, and community engagement, PASYKAF played a hands-on role in ensuring the EU Mobile App for Cancer Prevention is relevant, accessible, and trusted by diverse users. This gives the organization a chance to directly shape how cancer prevention information is shared with the public.
PASYKAF also helps to promote the app to the community, which boosts its experience in digital health education, enhance its visibility in public health innovation, and directly engage Cypriot citizens and professionals in the use of new digital tools. Through this work, PASYKAF strengthens its ability to reach more people with clear messages on cancer prevention.
As a result, PASYKAF not only contributes to building a more informed and health-literate public but also boosts its internal capabilities in digital health literacy, stakeholder engagement, and international research collaboration.
GATEKEEPER
Through its participation in the GATEKEEPER project, PASYKAF has significantly enhanced its capacity to provide high-quality, patient-centered cancer care using innovative digital health technologies.
As the main pilot site in Cyprus, PASYKAF tested smart technologies (smart watches) that helped monitor patients’ health and integrated them for the project’s purposes into existing palliative and home care frameworks. By using real-time patient data collected through the GATEKEEPER platform the organization improved its clinical decision-making, particularly for symptom monitoring and early intervention.
The active engagement of PASYKAF’s patients in reporting symptoms through the platform has allowed for more timely and effective therapeutic responses, reducing the need for unnecessary home visits and optimizing resource utilization. The project facilitated the overall use of digital platforms for PASYKAF, as it marked the organization’s novel experience in using smart technologies for patients’ health monitoring.
The project also bolstered PASYKAF’s visibility and credibility at both national and European levels, enhanced its research and innovation profile, and laid the groundwork for future EU collaborations. Furthermore, by organizing dissemination activities and engaging stakeholders through social media, press releases, and public events, PASYKAF strengthened its role as a leader in cancer care advocacy and digital health transformation.
